NL6605642A - - Google Patents

Info

Publication number
NL6605642A
NL6605642A NL6605642A NL6605642A NL6605642A NL 6605642 A NL6605642 A NL 6605642A NL 6605642 A NL6605642 A NL 6605642A NL 6605642 A NL6605642 A NL 6605642A NL 6605642 A NL6605642 A NL 6605642A
Authority
NL
Netherlands
Application number
NL6605642A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6605642A publication Critical patent/NL6605642A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J11/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
NL6605642A 1965-04-30 1966-04-27 NL6605642A (en:Method)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DESCH36966A DE1242610B (de) 1965-04-30 1965-04-30 Verfahren zur Herstellung von 1, 2beta-Methylen-5alpha-androstanderivaten
DESCH36965A DE1242609B (de) 1965-04-30 1965-04-30 Verfahren zur Herstellung von 1, 2beta-Methylen-5alpha-androstanderivaten

Publications (1)

Publication Number Publication Date
NL6605642A true NL6605642A (en:Method) 1966-10-31

Family

ID=25993264

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6605642A NL6605642A (en:Method) 1965-04-30 1966-04-27

Country Status (6)

Country Link
US (1) US3376197A (en:Method)
JP (1) JPS4930834B1 (en:Method)
CH (1) CH484086A (en:Method)
DE (2) DE1242609B (en:Method)
GB (1) GB1070115A (en:Method)
NL (1) NL6605642A (en:Method)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1187611B (de) * 1963-07-13 1965-02-25 Schering Ag Verfahren zur Herstellung von 3-Estern bzw. 3-AEthern des 1alpha, 2alpha-Methylen-delten-3, 17beta-diols und ihrer 17beta-Ester

Also Published As

Publication number Publication date
CH484086A (de) 1970-01-15
DE1242610B (de) 1967-06-22
US3376197A (en) 1968-04-02
GB1070115A (en) 1967-05-24
JPS4930834B1 (en:Method) 1974-08-16
DE1242609B (de) 1967-06-22

Similar Documents

Publication Publication Date Title
AU6702965A (en:Method)
BE674811A (en:Method)
BE675762A (en:Method)
BE665349A (en:Method)
BE666471A (en:Method)
BE668008A (en:Method)
BE668590A (en:Method)
BE669135A (en:Method)
BE675464A (en:Method)
BE670192A (en:Method)
BE671653A (en:Method)
BE673298A (en:Method)
BE673318A (en:Method)
BE673503A (en:Method)
BE673992A (en:Method)
BE673996A (en:Method)
BE674007A (en:Method)
BE674412A (en:Method)
BE674418A (en:Method)
BE674471A (en:Method)
BE674676A (en:Method)
BE674729A (en:Method)
BE674789A (en:Method)
BE675492A (en:Method)
BE674832A (en:Method)